Singapore markets closed

Quest Diagnostics Incorporated (DGX)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
146.01-0.83 (-0.57%)
At close: 04:00PM EDT
146.00 -0.01 (-0.01%)
After hours: 07:16PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 16.22B
Enterprise value 21.19B
Trailing P/E 19.65
Forward P/E 16.56
PEG ratio (5-yr expected) 1.71
Price/sales (ttm)1.75
Price/book (mrq)2.52
Enterprise value/revenue 2.27
Enterprise value/EBITDA 12.11

Trading information

Stock price history

Beta (5Y monthly) 0.88
52-week change 31.38%
S&P500 52-week change 320.87%
52-week high 3150.59
52-week low 3119.59
50-day moving average 3140.70
200-day moving average 3133.49

Share statistics

Avg vol (3-month) 3912.53k
Avg vol (10-day) 3855.94k
Shares outstanding 5111.09M
Implied shares outstanding 6111.15M
Float 8110.18M
% held by insiders 10.44%
% held by institutions 193.18%
Shares short (28 Jun 2024) 42.27M
Short ratio (28 Jun 2024) 42.74
Short % of float (28 Jun 2024) 42.34%
Short % of shares outstanding (28 Jun 2024) 42.04%
Shares short (prior month 31 May 2024) 42.65M

Dividends & splits

Forward annual dividend rate 43
Forward annual dividend yield 42.04%
Trailing annual dividend rate 32.88
Trailing annual dividend yield 31.96%
5-year average dividend yield 41.91
Payout ratio 448.32%
Dividend date 322 Jul 2024
Ex-dividend date 408 Jul 2024
Last split factor 22:1
Last split date 321 Jun 2005

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 9.11%
Operating margin (ttm)13.40%

Management effectiveness

Return on assets (ttm)6.20%
Return on equity (ttm)14.15%

Income statement

Revenue (ttm)9.29B
Revenue per share (ttm)83.11
Quarterly revenue growth (yoy)1.50%
Gross profit (ttm)N/A
EBITDA 1.78B
Net income avi to common (ttm)842M
Diluted EPS (ttm)7.43
Quarterly earnings growth (yoy)-4.00%

Balance sheet

Total cash (mrq)474M
Total cash per share (mrq)4.27
Total debt (mrq)5.35B
Total debt/equity (mrq)81.76%
Current ratio (mrq)0.97
Book value per share (mrq)57.95

Cash flow statement

Operating cash flow (ttm)1.33B
Levered free cash flow (ttm)784M